California to Allow Testing of Driverless Autonomous Cars
California has set new rules that will allow testing of self-driving cars without a safety driver, according to a report published in TechCrunch on February 27, 2018.
This announcement was made on Monday by the California Department of Motor Vehicles (DMV). The new rules allowing tech companies and other researchers working on autonomous cars to carry out testing of their cars without safety driver will come into effect from April 2 onwards.
Earlier, autonomous vehicle testing was approved by the DMV for many companies. However, behind the wheel, the cars approved for testing were to be provided with a trained safety driver. The new rules established will allow a test which is completely driverless. This is an important step for bringing these self-driving vehicles into the market.
Driverless cars does not mean that these cars will be on the roads without any human assistance. A remote operator will be connected to the car in case of any emergency. In case of any accident, the cars will be able to provide information about the owner and operator to some other people. There is a need for these cars to be strengthened against cyber-attacks. A permit has to be taken from the DMV if any companies wish to carry out this test. These rules that have been recently announced are only applicable to consumer passenger vehicles.
This will be a good news for Alphabet-owned Waymo and GM’s Cruise. Waymo’s version of driver-free test car is being tested in Arizona and driverless vehicle of Cruise was also recently showed off, which was a modified version of the Bolt EV. This new rule will help GM to field their cars by 2019.
The autonomous cars market, as detailed in the autonomous cars market report published by Coherent Market Insights, will observe an increase in their growth once these rules come into effect.
You may be interested
Medical Cannabis Market | Global Trends, and Forecast to 2025Albert R - April 21, 2018
Increasing approval of medicinal cannabis products and growing research and development activities in the medical cannabis market are expected to support the growth of the market. For…
Familial Amyloid Cardiomyopathy Treatment Market-Moving Towards a Brighter FutureAlbert R - April 21, 2018
Aggregation and deposition of mutant and wild-type transthyretin protein (TTR) in heart results in familial amyloid cardiomyopathy, which typically occur after age of 60. Familial amyloid cardiomyopathy…
3D Cell Culture Market To Witness Robust Expansion by 2024Albert R - April 21, 2018
3D cell culture is group of biological cells that are allowed to grow in artificial media in all three dimensions. It is used in drug discovery and…